HANGZHOU, China, July 10, 2023 /PRNewswire/ — Broncus Holding Corporation (HKG:2216) has completed the first case of registered clinical trials of its targeted lung denervation (”TLD”) radiofrequency ablation system. The multi-center clinical randomized controlled trial on the…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.